. Author manuscript; available in PMC: 2016 Apr 1.

Published in final edited form as: Am J Ophthalmol. 2014 Dec 19;159(4):764–776.e3. doi: 10.1016/j.ajo.2014.12.014

Table 3. Adjuvant Treatment and Metastasis in Tumors with Severe Anaplasia and High-Risk Histopathology Among 125 Cases of Retinoblastoma^*.

	Severe Anaplasia N=33 of 125 n (%)	High-Risk Histopathology N=42 of 125 n (%)
With Adjuvant Treatment	16 (48.5)	27 (64.3)
Without Adjuvant Treatment	17 (51.5)	15 (35.7)
Without metastasis	25 (75.8)	33 (78.6)
With metastasis	8 (24.2)	9 (21.4)

based on 125 cases with complete clinical data; adjuvant treatment was either systemic chemotherapy or systemic chemotherapy plus external beam radiation

Table 3. Adjuvant Treatment and Metastasis in Tumors with Severe Anaplasia and High-Risk Histopathology Among 125 Cases of Retinoblastoma*.

Table 3. Adjuvant Treatment and Metastasis in Tumors with Severe Anaplasia and High-Risk Histopathology Among 125 Cases of Retinoblastoma^*.